Evaluation of Taste Perception of Oncological Patients: Relationship with Personal and Clinical Variables and Comparison with a Control Group

Detalhes bibliográficos
Autor(a) principal: Maniglia, Fabíola Pansani
Data de Publicação: 2021
Outros Autores: Cruz, Leonice Caldeira da, Costa, Lauane Cristina Marques, Silva, Lara Coelho de Oliveira, Oliveira, Bruno Affonso Parenti de
Tipo de documento: Artigo
Idioma: por
eng
Título da fonte: Revista Brasileira de Cancerologia (Online)
DOI: 10.32635/2176-9745.RBC.2021v67n1.994
Texto Completo: https://rbc.inca.gov.br/index.php/revista/article/view/994
Resumo: Introduction: Antineoplastic treatment can cause side effects that impair the patients’ food intake and nutritional status. Objective: To evaluate the taste perception in patients undergoing cancer treatment, to relate it to personal and clinical variables and to compare with taste perception in healthy individuals. Method: Cross-sectional study with 50 individuals undergoing cancer treatment and another 50 individuals in the control group. To assess taste perception, participants received food samples and were asked about sweet, bitter, salty and sour flavors. The intensity of the flavor was assessed using a scale from 1 to 5. Results: Patients undergoing cancer treatment perceived the flavors of the following foods more strongly: dulce de leche (4.48±1.0 vs. 3.78±0.9; p<0.05), guava (4.10±1.0 vs. 3.52±0.9; p<0.05), lemon juice (4.42±0.9 vs. 2.86±1.0; p<0.05), passion fruit juice (3.76±1.2 vs. 2.56±1.0; p<0.05) and coffee (4.42±0.8 vs. 3.14±0.9; p<0.05). The foods: cassava starch, natural yogurt, arugula and chicory were perceived with less intensity when compared to the control group. Among the four flavor categories evaluated, the foods in the salty group were the ones that least differed in terms of the taste perception and sour and bitter foods were perceived more distinctly between the groups. Conclusion: The present study is pioneer in evaluating the taste perception using food, instead of standardized solutions, and through this technique, significant differences were identified in the intensity of taste perception of individuals undergoing cancer treatment.
id INCA-1_9adbc2fb1df38b4a904aeeab16668e62
oai_identifier_str oai:rbc.inca.gov.br:article/994
network_acronym_str INCA-1
network_name_str Revista Brasileira de Cancerologia (Online)
spelling Evaluation of Taste Perception of Oncological Patients: Relationship with Personal and Clinical Variables and Comparison with a Control GroupEvaluación de la Percepción del Sabor de Pacientes Oncológicos: Relación con Variables Personales y Clínicas y Comparación con un Grupo de ControlAvaliação da Percepção do Paladar de Pacientes Oncológicos: Relação com Variáveis Pessoais e Clínicas e Comparação com um Grupo ControleNeoplasiasOncologiaAntineoplásicos/efeitos adversosPaladarDisgeusiaNeoplasmsMedical Oncologyntineoplastic Agents/adverse effectsTasteDysgeusiaNeoplasiasOncología MédicaAntineoplásicos/efectos adversosGustoDisgeusiaIntroduction: Antineoplastic treatment can cause side effects that impair the patients’ food intake and nutritional status. Objective: To evaluate the taste perception in patients undergoing cancer treatment, to relate it to personal and clinical variables and to compare with taste perception in healthy individuals. Method: Cross-sectional study with 50 individuals undergoing cancer treatment and another 50 individuals in the control group. To assess taste perception, participants received food samples and were asked about sweet, bitter, salty and sour flavors. The intensity of the flavor was assessed using a scale from 1 to 5. Results: Patients undergoing cancer treatment perceived the flavors of the following foods more strongly: dulce de leche (4.48±1.0 vs. 3.78±0.9; p<0.05), guava (4.10±1.0 vs. 3.52±0.9; p<0.05), lemon juice (4.42±0.9 vs. 2.86±1.0; p<0.05), passion fruit juice (3.76±1.2 vs. 2.56±1.0; p<0.05) and coffee (4.42±0.8 vs. 3.14±0.9; p<0.05). The foods: cassava starch, natural yogurt, arugula and chicory were perceived with less intensity when compared to the control group. Among the four flavor categories evaluated, the foods in the salty group were the ones that least differed in terms of the taste perception and sour and bitter foods were perceived more distinctly between the groups. Conclusion: The present study is pioneer in evaluating the taste perception using food, instead of standardized solutions, and through this technique, significant differences were identified in the intensity of taste perception of individuals undergoing cancer treatment.Introducción: El tratamiento antineoplásico puede causar efectos secundarios que perjudican la ingesta de alimentos y el estado nutricional de los pacientes. Objetivo: Evaluar la percepción del gusto en pacientes sometidos a tratamiento contra el cáncer, relacionarlo con variables personales y clínicas y compararlo con la percepción del gusto en individuos sanos. Método: Este es un estudio transversal con 50 individuos en tratamiento contra el cáncer y otros 50 individuos en el grupo de control. Para evaluar la percepción del sabor, los participantes recibieron las muestras de alimentos y se les preguntó sobre los sabores dulces, amargos, salados y agrios. La intensidad del sabor se evaluó usando una escala del 1 al 5. Resultados: Los pacientes en tratamiento contra el cáncer percibieron los sabores de los siguientes alimentos con más fuerza: dulce de leche (4,48±1,0 vs. 3,78±0,9; p<0,05), guayaba (4,10±1,0 vs. 3,52±0,9; p<0,05), jugo de limón (4,42±0,9 vs. 2,86±1,0; p<0,05), jugo de maracuyá (3,76±1,2 vs. 2,56±1,0; p<0,05) y café (4,42±0,8 vs. 3,14±0,9; p<0,05). Los alimentos: galletas de almidón, yogur, rúcula y achicoria se percibieron con menos intensidad en comparación con el grupo de control. Entre los sabores, los alimentos salados fueron los que menos diferían y los alimentos amargos y amargos se percibieron más claramente entre los grupos. Conclusión: El presente estudio es pionero en evaluar la percepción del gusto utilizando alimentos, en lugar de soluciones estandarizadas, y identificó diferencias significativas en la intensidad de la percepción del gusto en individuos en tratamiento contra el cáncer.Introdução: O tratamento antineoplásico pode causar efeitos colaterais que prejudicam a ingestão alimentar e o estado nutricional dos pacientes. Objetivo: Avaliar a percepção do paladar de pacientes em tratamento oncológico, relacioná-la com as variáveis pessoais e clínicas e compará-la com a percepção do paladar de indivíduos sadios. Método: Trata-se de um estudo transversal com 50 indivíduos em tratamento oncológico e outros 50 indivíduos do grupo controle. Para avaliar a percepção do paladar, os participantes receberam amostras de alimentos e foram questionados quanto aos sabores doce, amargo, salgado e azedo. A intensidade do sabor foi avaliada por meio de uma escala de 1 a 5. Resultados: Os pacientes em tratamento oncológico perceberam os sabores dos seguintes alimentos de maneira mais acentuada: doce de leite (4,48±1,0 vs. 3,78±0,9; p<0,05), goiabada (4,10±1,0 vs. 3,52±0,9; p<0,05), suco de limão (4,42±0,9 vs. 2,86±1,0; p<0,05), suco de maracujá (3,76±1,2 vs. 2,56±1,0; p<0,05) e café (4,42±0,8 vs. 3,14±0,9; p<0,05). Já os alimentos: biscoito de polvilho, iogurte natural, rúcula e chicória foram percebidos com menor intensidade quando comparados ao grupo controle. Entre as quatro categorias de sabor avaliadas, os alimentos do grupo salgado foram os que menos se diferenciaram quanto à percepção do paladar e os alimentos azedos e amargos foram percebidos de forma mais distinta entre os grupos. Conclusão: O presente estudo é pioneiro em avaliar a percepção do paladar utilizando alimentos, ao invés de soluções padronizadas; e, por meio dessa técnica, identificaram-se diferenças significativas na intensidade da percepção do paladar dos indivíduos em tratamento oncológico.INCA2021-01-22info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionArtigos, Avaliado pelos paresapplication/pdfapplication/pdfhttps://rbc.inca.gov.br/index.php/revista/article/view/99410.32635/2176-9745.RBC.2021v67n1.994Revista Brasileira de Cancerologia; Vol. 67 No. 1 (2021): Jan./Feb./Mar.; e-11994Revista Brasileira de Cancerologia; Vol. 67 Núm. 1 (2021): ene./feb./mar.; e-11994Revista Brasileira de Cancerologia; v. 67 n. 1 (2021): jan./fev./mar.; e-119942176-9745reponame:Revista Brasileira de Cancerologia (Online)instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)instacron:INCAporenghttps://rbc.inca.gov.br/index.php/revista/article/view/994/878https://rbc.inca.gov.br/index.php/revista/article/view/994/1090Copyright (c) 2021 Revista Brasileira de Cancerologiainfo:eu-repo/semantics/openAccessManiglia, Fabíola Pansani Cruz, Leonice Caldeira da Costa, Lauane Cristina Marques Silva, Lara Coelho de OliveiraOliveira, Bruno Affonso Parenti de 2021-11-29T18:29:20Zoai:rbc.inca.gov.br:article/994Revistahttps://rbc.inca.gov.br/index.php/revistaPUBhttps://rbc.inca.gov.br/index.php/revista/oairbc@inca.gov.br0034-71162176-9745opendoar:2021-11-29T18:29:20Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)false
dc.title.none.fl_str_mv Evaluation of Taste Perception of Oncological Patients: Relationship with Personal and Clinical Variables and Comparison with a Control Group
Evaluación de la Percepción del Sabor de Pacientes Oncológicos: Relación con Variables Personales y Clínicas y Comparación con un Grupo de Control
Avaliação da Percepção do Paladar de Pacientes Oncológicos: Relação com Variáveis Pessoais e Clínicas e Comparação com um Grupo Controle
title Evaluation of Taste Perception of Oncological Patients: Relationship with Personal and Clinical Variables and Comparison with a Control Group
spellingShingle Evaluation of Taste Perception of Oncological Patients: Relationship with Personal and Clinical Variables and Comparison with a Control Group
Evaluation of Taste Perception of Oncological Patients: Relationship with Personal and Clinical Variables and Comparison with a Control Group
Maniglia, Fabíola Pansani
Neoplasias
Oncologia
Antineoplásicos/efeitos adversos
Paladar
Disgeusia
Neoplasms
Medical Oncology
ntineoplastic Agents/adverse effects
Taste
Dysgeusia
Neoplasias
Oncología Médica
Antineoplásicos/efectos adversos
Gusto
Disgeusia
Maniglia, Fabíola Pansani
Neoplasias
Oncologia
Antineoplásicos/efeitos adversos
Paladar
Disgeusia
Neoplasms
Medical Oncology
ntineoplastic Agents/adverse effects
Taste
Dysgeusia
Neoplasias
Oncología Médica
Antineoplásicos/efectos adversos
Gusto
Disgeusia
title_short Evaluation of Taste Perception of Oncological Patients: Relationship with Personal and Clinical Variables and Comparison with a Control Group
title_full Evaluation of Taste Perception of Oncological Patients: Relationship with Personal and Clinical Variables and Comparison with a Control Group
title_fullStr Evaluation of Taste Perception of Oncological Patients: Relationship with Personal and Clinical Variables and Comparison with a Control Group
Evaluation of Taste Perception of Oncological Patients: Relationship with Personal and Clinical Variables and Comparison with a Control Group
title_full_unstemmed Evaluation of Taste Perception of Oncological Patients: Relationship with Personal and Clinical Variables and Comparison with a Control Group
Evaluation of Taste Perception of Oncological Patients: Relationship with Personal and Clinical Variables and Comparison with a Control Group
title_sort Evaluation of Taste Perception of Oncological Patients: Relationship with Personal and Clinical Variables and Comparison with a Control Group
author Maniglia, Fabíola Pansani
author_facet Maniglia, Fabíola Pansani
Maniglia, Fabíola Pansani
Cruz, Leonice Caldeira da
Costa, Lauane Cristina Marques
Silva, Lara Coelho de Oliveira
Oliveira, Bruno Affonso Parenti de
Cruz, Leonice Caldeira da
Costa, Lauane Cristina Marques
Silva, Lara Coelho de Oliveira
Oliveira, Bruno Affonso Parenti de
author_role author
author2 Cruz, Leonice Caldeira da
Costa, Lauane Cristina Marques
Silva, Lara Coelho de Oliveira
Oliveira, Bruno Affonso Parenti de
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Maniglia, Fabíola Pansani
Cruz, Leonice Caldeira da
Costa, Lauane Cristina Marques
Silva, Lara Coelho de Oliveira
Oliveira, Bruno Affonso Parenti de
dc.subject.por.fl_str_mv Neoplasias
Oncologia
Antineoplásicos/efeitos adversos
Paladar
Disgeusia
Neoplasms
Medical Oncology
ntineoplastic Agents/adverse effects
Taste
Dysgeusia
Neoplasias
Oncología Médica
Antineoplásicos/efectos adversos
Gusto
Disgeusia
topic Neoplasias
Oncologia
Antineoplásicos/efeitos adversos
Paladar
Disgeusia
Neoplasms
Medical Oncology
ntineoplastic Agents/adverse effects
Taste
Dysgeusia
Neoplasias
Oncología Médica
Antineoplásicos/efectos adversos
Gusto
Disgeusia
description Introduction: Antineoplastic treatment can cause side effects that impair the patients’ food intake and nutritional status. Objective: To evaluate the taste perception in patients undergoing cancer treatment, to relate it to personal and clinical variables and to compare with taste perception in healthy individuals. Method: Cross-sectional study with 50 individuals undergoing cancer treatment and another 50 individuals in the control group. To assess taste perception, participants received food samples and were asked about sweet, bitter, salty and sour flavors. The intensity of the flavor was assessed using a scale from 1 to 5. Results: Patients undergoing cancer treatment perceived the flavors of the following foods more strongly: dulce de leche (4.48±1.0 vs. 3.78±0.9; p<0.05), guava (4.10±1.0 vs. 3.52±0.9; p<0.05), lemon juice (4.42±0.9 vs. 2.86±1.0; p<0.05), passion fruit juice (3.76±1.2 vs. 2.56±1.0; p<0.05) and coffee (4.42±0.8 vs. 3.14±0.9; p<0.05). The foods: cassava starch, natural yogurt, arugula and chicory were perceived with less intensity when compared to the control group. Among the four flavor categories evaluated, the foods in the salty group were the ones that least differed in terms of the taste perception and sour and bitter foods were perceived more distinctly between the groups. Conclusion: The present study is pioneer in evaluating the taste perception using food, instead of standardized solutions, and through this technique, significant differences were identified in the intensity of taste perception of individuals undergoing cancer treatment.
publishDate 2021
dc.date.none.fl_str_mv 2021-01-22
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Artigos, Avaliado pelos pares
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rbc.inca.gov.br/index.php/revista/article/view/994
10.32635/2176-9745.RBC.2021v67n1.994
url https://rbc.inca.gov.br/index.php/revista/article/view/994
identifier_str_mv 10.32635/2176-9745.RBC.2021v67n1.994
dc.language.iso.fl_str_mv por
eng
language por
eng
dc.relation.none.fl_str_mv https://rbc.inca.gov.br/index.php/revista/article/view/994/878
https://rbc.inca.gov.br/index.php/revista/article/view/994/1090
dc.rights.driver.fl_str_mv Copyright (c) 2021 Revista Brasileira de Cancerologia
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2021 Revista Brasileira de Cancerologia
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv INCA
publisher.none.fl_str_mv INCA
dc.source.none.fl_str_mv Revista Brasileira de Cancerologia; Vol. 67 No. 1 (2021): Jan./Feb./Mar.; e-11994
Revista Brasileira de Cancerologia; Vol. 67 Núm. 1 (2021): ene./feb./mar.; e-11994
Revista Brasileira de Cancerologia; v. 67 n. 1 (2021): jan./fev./mar.; e-11994
2176-9745
reponame:Revista Brasileira de Cancerologia (Online)
instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
instacron:INCA
instname_str Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
instacron_str INCA
institution INCA
reponame_str Revista Brasileira de Cancerologia (Online)
collection Revista Brasileira de Cancerologia (Online)
repository.name.fl_str_mv Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
repository.mail.fl_str_mv rbc@inca.gov.br
_version_ 1822182050887630848
dc.identifier.doi.none.fl_str_mv 10.32635/2176-9745.RBC.2021v67n1.994